Hi,

I'm facing 2 issues with our LLC and B16/F10 melanoma model in order to count lung metastasis.

In order to get significant metastasis, we need to incubate LLC and B16/F10 in mice for about a month. (LLC administration iv (tail vein): 5x10^5 cells/mouse / B16-F10: 1x10^6 cells/mouse IV).

At that endpoint, we obtain huge variation from mouse to mouse within the same experimental group.

How do you reduce this variation inside a same experimental group?

Is there another reliable cancer model to adresse metastasis in the lungs aside LLC/B16-F10 or urethane-induced?

thanks in advance

More Alexis Broquet's questions See All
Similar questions and discussions